Thomas Wickham
No más puestos en curso
Historial de carrera de Thomas Wickham
Antiguos cargos conocidos de Thomas Wickham.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RUBIUS THERAPEUTICS | Director Técnico/Científico/I+D | 01/10/2016 | 01/03/2019 |
| Corporate Officer/Principal | 01/03/2019 | 01/09/2020 | |
| MERRIMACK PHARMACEUTICALS, INC. | Director Técnico/Científico/I+D | 01/02/2009 | 01/10/2016 |
Lexigen Pharmaceuticals Corp.
 Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Corporate Officer/Principal | 01/02/2004 | 01/11/2008 |
| GENVEC INC | Corporate Officer/Principal | 01/11/1993 | 01/02/2004 |
Formación de Thomas Wickham.
| Carnegie Mellon University | Undergraduate Degree |
| Cornell University | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Lexigen Pharmaceuticals Corp.
Lexigen Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Lexigen Pharmaceuticals Corp. focuses on commercial physical and biological research. The company was founded by Stephen D. Gillies and is headquartered in Billerica, MA. | Commercial Services |
Rubius Therapeutics, Inc.
 Rubius Therapeutics, Inc. BiotechnologyHealth Technology Rubius Therapeutics, Inc. engages in the development of red-cell therapeutic medicines. It provides medicine for cancer, autoimmune diseases, hemophilia, infectious and metabolic diseases. The company was founded on April 26, 2013 and is headquartered in Foxboro, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Thomas Wickham
- Experiencia
